新...查看全文
Neon Therapeutics(NTGN)2020-03-31 20:05
$Neon Therapeutics(NTGN)$ 425 Prospectuses and communications, business combinations Accession Number: 0001564590-20-014382 Act: 34 Size: 752 KB 网页链接查看全文
Neon Therapeutics(NTGN)2020-04-01 04:15
$Neon Therapeutics(NTGN)$ 425 Prospectuses and communications, business combinations Accession Number: 0001564590-20-014533 Act: 34 Size: 412 KB 网页链接查看全文
Neon Therapeutics(NTGN)2020-03-26 08:45
$Neon Therapeutics(NTGN)$ 内部交易: 2020-03-24,10% Owner,Access Industries Holdings LLC ,卖出,117400普通股, $2.20查看全文
Neon Therapeutics(NTGN)2020-03-23 20:25
$Neon Therapeutics(NTGN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001770400-20-000003 Act: 34 Size: 43 KB 网页链接查看全文
Neon Therapeutics(NTGN)2020-03-24 09:10
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-020788 Size: 16 KB 网页链接查看全文
Neon Therapeutics(NTGN)2020-02-15 05:15
$Neon Therapeutics(NTGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-021666 Act: 34 Size: 150 KB 网页链接查看全文
Neon Therapeutics(NTGN)2020-03-03 07:45
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000029 Size: 4 KB 网页链接查看全文
医药魔方2021-07-22 09:36
7月19日,BioNTech宣布收购吉利德旗下公司Kite在马里兰州Gaithersburg的实体肿瘤新抗原T细胞受体(TCR)研发平台和临床生产工厂。该设施将支持BioNTech扩大新型细胞治疗管线的开发,包括基于其CAR-T细胞扩增mRNA疫苗(CARVac)和NEOSTIM平台的癌症候选产品,以及新获得的个体化新抗原TCR项目。
新...查看全文
正义创造力量2020-01-17 14:10
$Neon Therapeutics(NTGN)$ 最终协议的条款,在收购完成后,Neon将与Endor Lights, Inc.,一家特拉华州的公司和BioNTech的直接全资子公司合并,成为BioNTech的全资子公司。交易结束时,BioNTech将发行每股Neon股票,Neon股东将获得0.063股美国存托股票(ADS)(每份ADS代表1股BioNTech普通股)。根据Bi...查看全文
格格丫丫2020-01-16 22:08
$Neon Therapeutics(NTGN)$
这两天和业内人吃饭,聊起最近的行业发展趋势,刚好提到新生抗原开始热了起来,好巧,这边的收购就来了,是JP Morgan?查看全文
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000062 Size: 12 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000063 Size: 12 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000064 Size: 10 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000065 Size: 12 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000066 Size: 8 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000067 Size: 8 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000068 Size: 10 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000069 Size: 10 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000070 Size: 12 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000071 Size: 10 KB 网页链接